Clamp Down on Cheap Medications
With the demand rising for cheaper pharmacy medications, manufacturers are pushing hard to stop the flow of generic medicines from entering USA.
Roche announced Friday that, working with 15 partners, it would increase production of Tamiflu by 33 percent by year's end. The company is aware that competition from manufacturers of generic medicines are targeting the product because of the increased demand for bird-flu treatments.
The U.S. Drug Enforcement Administration, said that they have seen an increase in bogus treatments for high cholesterol, hypertension and obesity. Some generic drugs include products made with incorrect or no active ingredients, the wrong amount of medicine or by unlicensed manufacturers.
In 2004, Britain reported finding counterfeit versions of Reductil, an obesity treatment made by Abbott Laboratories, and copies of Cialis, an impotence drug manufactured by Eli Lilly. A year earlier, shipments of generic Lipitor, the cholesterol drug from Pfizer, made their way into drugstores in the United States.
The growth of Internet pharmacies has increased with the high demand for cheaper medications. Unfortunately, it has also created an opportunity for counterfeiters because consumers often do not know whom they are buying from. The International Federation of Pharmaceutical Manufacturers Associations in Geneva believe saales of prescription drugs over the Web may grow to $13.8 billion next year from $3.2 billion in 2003, according to Jupitermedia, a research firm based in Connecticut.
Seizures of generic drugs rose 40 percent last year, with Russia overtaking China for the first time as the country with the highest number of confiscations, according to a study by the Pharmaceutical Security Institute, based in Vienna, Virginia, which was founded in 2002 by the security directors of 14 drug makers.
The European Union has become more open to the importing of generic medicines since it expanded to include countries bordering Russia.
The arguements for and against the development of generic medications are many and complex. The big pharmaceutical companies claim that generic drugs undermine the research work for new drugs. In contrast to the generic manufacturers state that "big pharma" make excessive profits from patented medicines. Adding that much of the research is focussed on finding ways to modify an existing medication so that a new patent or extended patent can be applied.
The pharmacy ratings listing for reliable brand name and generic online pharmacies is an extensive guide, researched and built over a 5 year period. The independently compiled pharmacy comparison guide shows many trusted pharmacies, rated by performance.
An additional list of pharmacies to avoid and pharmacies that have closed is also maintained and updated. This list has a better alternative pharmacy option to consider listed against every avoid or closed pharmacy.
Roche announced Friday that, working with 15 partners, it would increase production of Tamiflu by 33 percent by year's end. The company is aware that competition from manufacturers of generic medicines are targeting the product because of the increased demand for bird-flu treatments.
The U.S. Drug Enforcement Administration, said that they have seen an increase in bogus treatments for high cholesterol, hypertension and obesity. Some generic drugs include products made with incorrect or no active ingredients, the wrong amount of medicine or by unlicensed manufacturers.
In 2004, Britain reported finding counterfeit versions of Reductil, an obesity treatment made by Abbott Laboratories, and copies of Cialis, an impotence drug manufactured by Eli Lilly. A year earlier, shipments of generic Lipitor, the cholesterol drug from Pfizer, made their way into drugstores in the United States.
The growth of Internet pharmacies has increased with the high demand for cheaper medications. Unfortunately, it has also created an opportunity for counterfeiters because consumers often do not know whom they are buying from. The International Federation of Pharmaceutical Manufacturers Associations in Geneva believe saales of prescription drugs over the Web may grow to $13.8 billion next year from $3.2 billion in 2003, according to Jupitermedia, a research firm based in Connecticut.
Seizures of generic drugs rose 40 percent last year, with Russia overtaking China for the first time as the country with the highest number of confiscations, according to a study by the Pharmaceutical Security Institute, based in Vienna, Virginia, which was founded in 2002 by the security directors of 14 drug makers.
The European Union has become more open to the importing of generic medicines since it expanded to include countries bordering Russia.
The arguements for and against the development of generic medications are many and complex. The big pharmaceutical companies claim that generic drugs undermine the research work for new drugs. In contrast to the generic manufacturers state that "big pharma" make excessive profits from patented medicines. Adding that much of the research is focussed on finding ways to modify an existing medication so that a new patent or extended patent can be applied.
The pharmacy ratings listing for reliable brand name and generic online pharmacies is an extensive guide, researched and built over a 5 year period. The independently compiled pharmacy comparison guide shows many trusted pharmacies, rated by performance.
An additional list of pharmacies to avoid and pharmacies that have closed is also maintained and updated. This list has a better alternative pharmacy option to consider listed against every avoid or closed pharmacy.
posted by Clive Wallace at 2:41 PM
<< Home